Terms: = Germ cell tumor AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Treatment
1398 results:
1. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
Huang R; Kong Y; Luo Z; Li Q
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
[TBL] [Abstract] [Full Text] [Related]
3. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
4. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors.
Cheng Y; Dai Y; Tang H; Lu X; Xie J; Xie W; Zhang Q; Liu Y; Lin S; Yao H; Shang H; Yang K; Liu H; Wu X; Zhang J; Zhang X; Xue L; Wu ZB
Acta Neuropathol Commun; 2024 Apr; 12(1):61. PubMed ID: 38637883
[TBL] [Abstract] [Full Text] [Related]
7. Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
8. The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.
Wang Y; Wu N; Li J; Liang J; Zhou D; Cao Q; Li X; Jiang N
Pharmacol Res; 2024 May; 203():107162. PubMed ID: 38554788
[TBL] [Abstract] [Full Text] [Related]
9. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
Ji Q; Guo Y; Li Z; Zhang X
Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
[TBL] [Abstract] [Full Text] [Related]
10. Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking.
Cheung S; Zhong Y; Wu L; Jia X; He MQ; Ai Y; Jiao Q; Liang Q
J Ethnopharmacol; 2024 Jun; 328():117976. PubMed ID: 38492794
[TBL] [Abstract] [Full Text] [Related]
11. Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential.
Li D; Wang J; Tuo Z; Yoo KH; Yu Q; Miyamoto A; Zhang C; Ye X; Wei W; Wu R; Feng D
Phytomedicine; 2024 May; 127():155503. PubMed ID: 38490077
[TBL] [Abstract] [Full Text] [Related]
12. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem cells, and Therapeutic Targets.
Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients.
Zhang T; Zhang Q; He X; Lu Y; Shao A; Sun X; Shao Y
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474320
[TBL] [Abstract] [Full Text] [Related]
14. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract] [Full Text] [Related]
15. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
16. Daurisoline suppress glioma progression by inhibiting autophagy through pi3k/AKT/mTOR pathway and increases TMZ sensitivity.
Yin HT; Hui-Lu ; Yang JH; Li Q; Li M; Zhao QQ; Wen ZP
Biochem Pharmacol; 2024 May; 223():116113. PubMed ID: 38460907
[TBL] [Abstract] [Full Text] [Related]
17. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract] [Full Text] [Related]
18. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
19. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.
Ezzati S; Salib S; Balasubramaniam M; Aboud O
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396993
[TBL] [Abstract] [Full Text] [Related]
20. Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma.
Zhang Y; Wu W; Xu C; Yang H; Huang G
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):34. PubMed ID: 38393716
[TBL] [Abstract] [Full Text] [Related]
[Next]
